Cargando…
The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growth
Altered DAB2IP gene expression often detected in prostate cancer (PCa) is due to epigenetic silencing. In this study, we unveil a new mechanism leading to the loss of DAB2IP protein; an oncogenic S-phase kinase-associated protein-2 (Skp2) as E3 ubiquitin ligase plays a key regulator in DAB2IP degrad...
Autores principales: | Tsai, Yuh-Shyan, Lai, Chen-Li, Lai, Chih-Ho, Chang, Kai-Hsiung, Wu, Kaijie, Tseng, Shu-Fen, Fazli, Ladan, Gleave, Martin, Xiao, Guanghua, Gandee, Leah, Sharifi, Nima, Moro, Loredana, Tzai, Tzong-Shin, Hsieh, Jer-Tsong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171641/ https://www.ncbi.nlm.nih.gov/pubmed/25115390 |
Ejemplares similares
-
DAB2IP in cancer
por: Liu, Liang, et al.
Publicado: (2015) -
DAB2IP modulates primary cilia formation associated with renal tumorigenesis
por: Lin, Chun-Jung, et al.
Publicado: (2020) -
The network of DAB2IP-miR-138 in regulating drug resistance of renal cell carcinoma associated with stem-like phenotypes
por: Yun, Eun-Jin, et al.
Publicado: (2017) -
Downregulation of DAB2IP Promotes Mesenchymal-To-Neuroepithelial Transition and Neuronal Differentiation of Human Mesenchymal Stem Cells
por: Chang, Sunny Li-Yun, et al.
Publicado: (2013) -
DAB2IP loss confers the resistance of prostate cancer to androgen deprivation therapy through activating STAT3 and inhibiting apoptosis
por: Zhou, J, et al.
Publicado: (2015)